CBT and BT: Some effect against chronic pain

April 15, 2009,

Cognitive Behaviour Therapy (CBT) and Behaviour Therapy (BT) show some effect in helping the disability associated with chronic pain, according to a Cochrane Systematic Review. The researchers assessed the use of CBT and BT on chronic pain, mood, and disability.

"For people with , psychological therapies can reduce and , disability, and in some cases pain, but guidance is still required on the best type and duration of treatment," says lead researcher Christopher Eccleston, at the Centre for Pain Research at the University of Bath.

Both CBT and BT try to manage pain by addressing the associated psychological and practical processes. CBT involves the avoidance of negative thoughts. BT helps patients to understand how they can change their behaviour in order to reduce pain. Both approaches have been in development for around 40 years and are sometimes recommended for patients with long lasting, distressing pain that cannot be relieved by conventional medicines.

In a systematic review, researchers considered the results of 40 trials of CBT and BT, which included 4,781 patients in total. suffering from pain due to any cause, except headache, , or cancer, were included. Most studies were of CBT, which showed small positive effects on pain, disability, and mood. There was less evidence for BT, which the researchers say had no effect on disability or mood.

"Although there is overall promise for CBT in chronic pain, the term covers a diverse range of treatment and assessment procedures. Right now, we are not able to say which specific features of therapy may be critical for improvement of a patient's condition," says Eccleston.

According to the researchers, simpler studies of CBT and BT that focus on a purer form of treatment, rather than a variety of mixed methods, would benefit the field.

Source: Wiley (news : web)

Related Stories

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.